Evotec (EVT GY) announced it expects to receive approximately USD 100mln in upfront consideration upon closing of the sale of Tubulis to Gilead Sciences (GILD)
Importance
Level 1
#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#GILEAD SCIENCES INC#GILD.US#EVOTEC AG#EVT.GY#FOREX#EQUITIES#METALS#EU SESSION#US SESSION#BIOTECHNOLOGY#METALS & MINING#BIOTECHNOLOGY (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#NASDAQ 100 INDEX#GILD#DXY#EUROPEAN EQUITIES